Mural Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-	-207.45	-189.81	-175.43
Depreciation & Amortization	-	2.57	1.54	1.47
Share-Based Compensation	-	24.11	11.93	11.5
Other Operating Activities	-	-13.48	7.75	5.79
Operating Cash Flow	-	-194.25	-168.59	-156.67
Capital Expenditures	-	-3.45	-5.51	-4.39
Investing Cash Flow	-	-3.45	-5.51	-4.39
Other Financing Activities	-	468.81	174.1	161.05
Financing Cash Flow	-	468.81	174.1	161.05
Net Cash Flow	-	271.11	0	0
Free Cash Flow	-	-197.7	-174.1	-161.05
Free Cash Flow Per Share	-	-11.85	-10.43	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).